App-Quantinova.ai

Covid-19 Registry to Assess Frequency, Management, and Outcomes of Arterial and Venous Thromboembolic Complications (CORONA-VTE)

Gregory Piazza - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

N/A

Reduction in Venous Thromboembolism With Rivaroxaban versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD

Connie N Hess - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

Immune Checkpoint Inhibitors for Cancer Are Associated With Increased Venous Thromboembolism Events

Jingyi Gong - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Novel Oral Anticoagulants Are Associated With Decreased Recurrence of Venous Thromboembolism in Patients With Cancer: An Updated Meta-Analysis

Sunil Upadhaya - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Heparin

Direct Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism in Obese Patients: A Systematic Review With Meta-analysis

Vicky Mai - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical Characteristics, Treatment Patterns, and Short-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis

Cesar Caraballo - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Anticoagulation Treatment of Venous Thromboembolism Across the Weight Spectrum: Insights From the Veterans Health Administration

Alexander C Perino - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fondaparinux sodium

Risk of Thrombotic Events After Respiratory Infection Requiring Hospitalization

Nathaniel R Smilowitz - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Arterial and Venous Thromboembolism in Covid-19: A Study-level Meta-analysis

Vicky Mai - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

N/A

Fondaparinux: A Low-hanging Fruit in Heparin-induced Thrombocytopenia

Jose P Sousa - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fondaparinux sodium

Evaluation of cabozantinib (cabo) in combination with direct oral anticoagulants (DOAC) or low molecular weight heparin (LMWH) in renal cell carcinoma (RCC).

Akram Mesleh Shayeb - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Cabozantinib

A retrospective real-world major bleeding (MB) comparison of direct oral anticoagulants (DOAC) and low molecular weight heparin (LMWH) in genitourinary cancer-associated venous thromboembolism (GU-CAVTE) with reported randomized clinical trials (RTC).

Ulyana Dashkevych - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Heparin

The relation between plasminogen activator inhibitor-1 (PAI-1) and inflammatory markers in COPD: A possible risk factor of inflammation-induced thrombosis

Mehmet Polatli - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Hemostatic potential evaluation of patient with COPD by low-frequency piezoelectric thromboelastography

Anna Bulanova - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Hemostatic Solution

Silent venous thromboembolism (VTE) in patients undergoing thoracic surgery in the course of lung cancer

Pawel Kuca - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

Clinical gestalt and the prognosis of pulmonary embolism

David Jimnez Castro - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Methadone hydrochloride

Effect of vascular endothelial related factors in patients with venous thromboembolism

Jin Zhang - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical significance of deep venous thrombosis in symptomatic pulmonary embolism

Nataliya Stoeva - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Proangiogenic and wound healing molecular and histological fingerprint of chronic thromboembolic pulmonary hypertension

Dijana Iloska - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Vascular sexual dimorphism and pulmonary hypertension in a rat chronic hypoxia model

Jesus Prieto-Lloret - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

carbachol drops

Filters

7277 Abstracts